Publicaciones en colaboración con investigadores/as de Novartis (Sweden) (3)

2020

  1. Comparison of first-line and second-line use of fingolimod in relapsing MS: The open-label EARLIMS study

    Multiple Sclerosis Journal - Experimental, Translational and Clinical, Vol. 6, Núm. 3

2019

  1. Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: An analysis from the randomized transform study

    Transplantation, Vol. 103, Núm. 9, pp. 1953-1963

2007

  1. Impact of long-term therapy with FTY720 or mycophenolate mofetil on cardiac conduction and rhythm in stable adult renal transplant patients

    Transplantation, Vol. 83, Núm. 5, pp. 645-648